The Data Speaks for Itself
Real outcomes from real communities \u2014 see how pharmacy-based screening is changing healthcare access.
Cone Health Pilot
6 Pharmacies. 3 Counties. 20 Months.
5,400+
patients screened
96%
with at least 1 abnormal result
93% abnormal
but only 35% previously diagnosed
207
hypertensive crises caught
78%
follow-up opt-in rate
$2–2.5M
Year 1 revenue
5–10x
ROI
Diverse Population Reached
49%
Black
34%
White
11%
Hispanic
6%
Other
86%
had diabetes and/or hypertension
41%
had no PCP or hadn't seen one in 12+ months
Financial Outcomes
$427K
Total Program Cost
5–10x
Return on Investment
$2–2.5M
Estimated Year 1 Revenue
Clinical Trial Recruitment
The Untapped Recruitment Channel
Pharmacists know their patients. A pharmacist can recommend a colon cancer screening to a 50+ male patient they see every month — something no targeted ad can replicate.
Identify
Pharmacists Know Who Qualifies
Pharmacists see patients 10x more often than any other provider. They know medication histories, conditions, and demographics — making them natural pre-screeners for trial eligibility.
Screen
Point-of-Care Qualification
Digital surveys and in-person screening at the pharmacy counter. No travel to a clinical site, no intimidating hospital setting — just a trusted community touchpoint.
Recruit
Diverse Enrollment at Scale
56% of our pharmacies are in socially vulnerable areas. This isn't diversity as an afterthought — it's built into the infrastructure.
Recruitment Results Across 9 Active Trials
9
active clinical trials
6
therapeutic areas
3
CRO/sponsor partners
49%
Black participants in pilot
Partners: IQVIA (6 trials) · 83bar (2 trials) · Veda (1 trial)
What Cone Health Says
“This innovative partnership helps us break down barriers… more people get access to the preventative screenings they need.”
“Healthcare systems are incentivized to partner with SiteLabs to improve health outcomes and increase revenue.”
Want Results Like These?
Request a demo to see how pharmacy-based screening can work for your organization.